ライフサイエンスコーパス: years or older

1 Electronic medical record (EMR) data from patients 10 years or older were reviewed to determine the rates at which

2 treatment of seasonal allergic rhinitis in persons aged 12 years or older, routinely prescribe monotherapy with an intra

3 ate to severe seasonal allergic rhinitis in persons aged 12 years or older, the clinician may recommend the combination o

4 Eligible patients were aged 15 years or older with a diagnosis of an advanced unresectable o

5 Community residents who were 15 years or older (N = 77774) were followed up for 2 years (2013

6 All participants were aged 16 years or older.

7 Among patients 16 years or older with an acute, displaced, extra-articular frac

8 Eligible patients were aged 18 years or older and had histologically confirmed, previously u

9 ir and emtricitabine) in HIV serodiscordant couples aged 18 years or older in Kenya and Uganda that showed high efficacy

10 We enrolled patients aged 18 years or older with HCV genotype 1, 2, 4, 5, or 6 infection a

11 Eligible patients were aged 18 years or older with histologically or cytologically confirmed

12 Postmenopausal women aged 18 years or older with histologically or cytologically confirmed

13 Eligible patients were aged 18 years or older, had a diagnosis of chronic plaque psoriasis f

14 Eligible patients were aged 18 years or older, had a platinum-sensitive, high-grade serous o

15 Participants aged 18 years or older, with mild to moderate intellectual disabiliti

16 Inclusion criteria were age of 18 years or older and willingness to participate.

17 In the economic model, the total Belgian population 18 years or older was assumed to have been invited for the scree

18 Patients were those 18 years or older with dermatologic complaints who would have ot

19 All patients were 18 years or older and underwent exercise treadmill testing.

20 vived 10 years or longer from initial diagnosis and were 18 years or older as of June 30, 2015.

21 All patients were 18 years or older with a diagnosis of LyP and were also required

22 Participants were 18 years or older, had Diagnostic and Statistical Manual of Ment

23 ent [n = 67; 6.5%]), the late phenotype with onset at age 2 years or older (n = 50; 4.8%), and the never/infrequent pheno

24 We did a cohort study of women in Scotland aged 20 years or older undergoing a first, single incontinence proced

25 y of a quality improvement program studied 2420 patients 20 years or older with symptoms or signs consistent with STEMI a

26 sons in the United States with diabetes diagnosed at age 30 years or older.

27 Veterans Affairs Palo Alto Health Care System, patients 35 years or older scheduled for an annual health habits screen i

28 Patients aged 4 years or older with a history of moderate to severe attacks w

29 dwide age-standardised prevalence in the population aged 40 years or older is about 3.5%.

30 being at high risk for COPD (defined as individuals aged 40 years or older, with cumulative tobacco consumption of ten pa

31 Women aged 50 years or older who had undergone breast-conserving surgery fo

32 6 eligible participants who self-identified as black and 50 years or older with chronic and frequent knee pain, a Western

33 tion model of osteoporosis for postmenopausal women aged 55 years or older was developed with a lifetime horizon and U.S.

34 A total of 251 patients aged 6 years or older at baseline, harboring disease-causing variant

35 defined as severe or moderate to severe) for adults aged 60 years or older (n = 16,770) over 3 time periods in the Nation

36 at clinicians select the treatment goals for adults aged 60 years or older based on a periodic discussion of the benefits

37 g estimates of past-year abuse prevalence in adults aged 60 years or older were included in the analyses.

38 g or intensifying pharmacologic treatment in adults aged 60 years or older with a history of stroke or transient ischemic

39 ommend that clinicians initiate treatment in adults aged 60 years or older with systolic blood pressure persistently at o

40 commended), 20 to 59 years (no vaccine recommended), and 60 years or older (HZ vaccine recommended).

41 owel diseases (IBD) is increasing among elderly persons (60 years or older).

42 rtificate (IRR, 1.29; 95% CI, 1.07-1.54), those who were 60 years or older (IRR, 1.32; 95% CI, 1.06-1.63), and those with

43 analysis of Medicare fee-for-service beneficiaries aged 65 years or older from 1999 to 2014 using the Medicare Inpatient

44 The participants were 170 of 788 men aged 65 years or older with an average of 2 serum testosterone levels

45 ategorized as younger than 40 years, 40 to 64 years, and 65 years or older for multivariable analysis.

46 Sixty-six participants 65 years or older with PAD were randomized to receive a daily ca

47 GI bleeding events among patient aged 75 years or older taking DOACs increased with age; the risk was

48 104 black persons and 104 white persons aged 8 years or older who had had type 1 diabetes for at least 2 yea

49 (PRETEXT) group; age younger than 3 years, 3-7 years, and 8 years or older; alpha fetoprotein (AFP) concentration of 100

50 iduals younger than 65 years, to 25 for individuals aged 85 years or older.